Influence and significance of intervening diabetes microRNA expression profile of NOD mice with exendin-4

被引:0
|
作者
He, J. -S. [1 ]
Lian, C. -W. [1 ]
Fang, Y. -L. [1 ]
Wu, J. -Z. [2 ]
Ye, X. -L. [1 ]
Zhu, S. -B. [1 ]
机构
[1] Fujian Med Univ, Zhangzhou Hosp Affiliated, Dept Pediat, Zhangzhou, Fujian Province, Peoples R China
[2] Fujian Med Univ, Zhangzhou Hosp Affiliated, Dept Endocrinol, Zhangzhou, Fujian Province, Peoples R China
关键词
Exendin-4; microRNA; Non obese; Diabetes mellitus; Pancreatic injury; MYOCARDIAL-INFARCTION; ERECTILE DYSFUNCTION; CELLS; GROWTH; RECEPTOR; TYPE-2; ROLES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To provide selectable microRNA for intervening diabetes mellitus diseases, NOD mice's expression of microRNA in pancreas tissues and blood under the exendin-4 intervention of was observed and the difference of microRNA target gene was screened. MATERIALS AND METHODS: Forty clean NOD mice were randomly divided into four groups (in each group, n = 10): One is blank control group D which is intervened with normal saline, and the other three groups were divided into low-dose group A, middle-dose group B, and high-dose group C according to the different exendin- 4 dosage 2, 4, and 8 mu g/kg.d. After the 8-week intervention, these four groups were killed, and the pancreatic tissue and blood were left to prepare specimens for morphology and molecular biology analysis. The specimen with differential expression microRNA in pancreas tissue and blood should be screened out after detected with the locked nucleic acid array system (LNATM) microRNA expression profile chip. The primers should be designed, and the ABI7500 real-time fluorescent quantitative PCR should be applied to amplify, analyze, and verify according to the screen results of the microRNA chip in order to screen out the significant differentially expressed microRNA. RESULTS: Histological detection showed that the pancreas of the mice in control group D was fibrosis gradually and the islet frame was relatively disordered and significantly atrophied. Groups A, B, and C have no islet hypertrophy or atrophy and the degree of fibrosis of the pancreas has reduced. According to the gene chip detection, there are four significantly differently expressed microRNAs in pancreas tissue and blood among the group A, B, and C, among which miR-19a, miR-19b, and miR-22 were down-regulated expressed while the miRNA-1 was upregulated expressed. Bioinformatics analysis showed that the target genes of 4 differentially regulated microRNA genes were related to cell proliferation, apoptosis, glucose metabolism, and angiogenesis. The expression of microRNA in pancreatic tissue and blood of NOD rats was highly consistent. CONCLUSIONS: MicroRNA expression file of pancreatic tissue and blood can be changed during the intervention of the NOD rat model with exendin-4. MicroRNA that indicates the differential expression may take part in the recovering process of the NOD pancreatic trauma. At the same time, the administration of exendin- 4 can protect NOD mice, reduce its pancreatic tissue fibrosis, and regulate molecular markers of pancreatic cells in size and pancreatic mast cells. This may be one of the main mechanisms of pancreatic injury in diabetes prevention.
引用
下载
收藏
页码:4322 / 4327
页数:6
相关论文
共 50 条
  • [1] Exendin-4 delays diabetes onset and reduces the severity of insulitis in NOD mice
    Hadjiyanni, Irene
    Baggio, Laurie L.
    Poussier, Philippe
    Drucker, Daniel J.
    DIABETES, 2007, 56 : A372 - A373
  • [3] Reversal of type-1 diabetes in NOD mice with combination of exendin-4 and lisofylline
    Carter, JD
    Chen, M
    Smith, KM
    Nadler, JL
    Yang, Z
    DIABETES, 2005, 54 : A67 - A67
  • [4] Prevention and Reversal of Diabetes by All-Trans Retinoid Acid and Exendin-4 in NOD Mice
    Juang, Jyuhn-Huarng
    Van, Yang-Hau
    Kuo, Chien-Hung
    Lin, Mei-Yin
    Liu, Ying-Hsiu
    Chang, Han-Ying
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2014, 2014
  • [5] Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4
    Ogawa, N
    List, JF
    Habener, JF
    Maki, T
    DIABETES, 2004, 53 (07) : 1700 - 1705
  • [6] Exendin-4 Therapy in NOD Mice with New-Onset Diabetes Increases Regulatory T Cell Frequency
    Xue, Song
    Wasserfall, Clive H.
    Parker, Matthew
    Brusko, Todd M.
    McGrail, Sean
    McGrail, Kieran
    Moore, Marcus
    Campbell-Thompson, Martha
    Schatz, Desmond A.
    Atkinson, Mark A.
    Haller, Michael J.
    IMMUNOLOGY OF DIABETES V: FROM BENCH TO BEDSIDE, 2008, 1150 : 152 - 156
  • [7] Exendin-4 modulates diabetes onset in nonobese diabetic mice
    Hadjiyanni, Irene
    Baggio, Laurie L.
    Poussier, Philippe
    Drucker, Daniel J.
    ENDOCRINOLOGY, 2008, 149 (03) : 1338 - 1349
  • [8] Prevention and Rescue of Diabetes by All-Trans Retinoid Acid and Exendin-4 in NOD Mice with and Without Islet Transplantation
    Juang, Jyuhn-Huarng
    Van, Yang-Hau
    Kuo, Chien-Hung
    Liu, Ying-Hsiu
    Chang, Han-Yin
    TRANSPLANTATION, 2013, 96 (06) : S20 - S20
  • [9] Effects of All-Trans Retinoid Acid and Exendin-4 on Islet Transplantation in NOD Mice
    Juang, J. -H.
    Kuo, C. -H.
    Liu, Y. -H.
    Chang, H. -Y.
    Van, Y. -H.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (06) : 1950 - 1952
  • [10] Microbial expression of Exendin-4 analog and its efficacy in mice model
    Kodaganti, Bhargav Prasad
    Mukunda, Pavithra
    Dakshinamurthy, Pravinkurriar
    Manjunath, Yogendra
    Shenoy, Bharath Ravindra
    Kamanagowda, Veeresha
    Natarajan, Bairavabalakumar
    Maliwalave, Amol
    Unnikrishnan, Divya
    Murugesan, Sathyabalan
    Halan, Vivek
    Ghosh, Maloy
    Maity, Sunit
    BIOLOGICALS, 2017, 48 : 82 - 91